Literature DB >> 4030780

Arachidonoyl-CoA synthetase. Separation from nonspecific acyl-CoA synthetase and distribution in various cells and tissues.

M Laposata, E L Reich, P W Majerus.   

Abstract

Arachidonoyl-CoA synthetase was solubilized from a particulate fraction of calf brain and human platelets using 1% Nonidet P-40 and 10 mM EDTA. Arachidonoyl-CoA synthetase from both preparations was separated from nonspecific (long chain) acyl-CoA synthetase (EC 6.2.1.3) by chromatography on hydroxylapatite. To further substantiate that the two acyl-CoA synthetases are distinct proteins, we solubilized enzyme from a mutant cell line lacking arachidonoyl-CoA synthetase and from the parent cell line from which it was derived. These preparations were chromatographed on hydroxylapatite, and the mutant showed an absence of the peak identified as arachidonoyl-CoA synthetase in the parent while retaining the peak of nonspecific acyl-CoA synthetase activity. We have also determined the levels of arachidonoyl and nonspecific acyl-CoA synthetase in 13 different human cells and tissues. Arachidonoyl-CoA synthetase is widely distributed and is present in significantly lower concentrations than nonspecific acyl-CoA synthetase only in adipose tissue and liver.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4030780

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Identical subcellular distribution of palmitoyl-CoA and arachidonoyl-CoA synthetase activities in human blood platelets.

Authors:  A M Bakken; M Farstad
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

2.  Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoyl-CoA by brain microsomal long-chain fatty acyl-CoA synthetases: relevance to bipolar disorder.

Authors:  Richard P Bazinet; Margaret T Weis; Stanley I Rapoport; Thad A Rosenberger
Journal:  Psychopharmacology (Berl)       Date:  2005-12-13       Impact factor: 4.530

3.  Rat brain docosahexaenoic acid metabolism is not altered by a 6-day intracerebral ventricular infusion of bacterial lipopolysaccharide.

Authors:  Thad A Rosenberger; Nelly E Villacreses; Margaret T Weis; Stanley I Rapoport
Journal:  Neurochem Int       Date:  2009-12-22       Impact factor: 3.921

4.  The distribution and metabolism of arachidonate-containing phospholipids in cellular nuclei.

Authors:  M E Surette; F H Chilton
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

5.  Acyl-CoA synthetase activity in liver microsomes from calcium-deficient rats.

Authors:  C A Marra; M J de Alaniz
Journal:  Lipids       Date:  1999-04       Impact factor: 1.880

6.  Relation between free fatty acid and acyl-CoA concentrations in rat brain following decapitation.

Authors:  J Deutsch; S I Rapoport; A D Purdon
Journal:  Neurochem Res       Date:  1997-07       Impact factor: 3.996

7.  Total and peroxisomal oxidation of various saturated and unsaturated fatty acids in rat liver, heart and m. quadriceps.

Authors:  F A Reubsaet; J H Veerkamp; J M Trijbels; L A Monnens
Journal:  Lipids       Date:  1989-11       Impact factor: 1.880

8.  Identity between palmitoyl-CoA synthetase and arachidonoyl-CoA synthetase in human platelet?

Authors:  A M Bakken; M Farstad; H Holmsen
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

9.  Saturability of esterification pathways of major monohydroxyeicosatetraenoic acids in rat basophilic leukemia cells.

Authors:  P B Costello; A N Baer; F A Green
Journal:  Inflammation       Date:  1991-08       Impact factor: 4.092

Review 10.  Very long chain fatty acids in higher animals--a review.

Authors:  A Poulos
Journal:  Lipids       Date:  1995-01       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.